Search Results for: mayo clinic

Diagnosing and Treating Carcinoid: The Dana-Farber Experience

Presented by
Matthew Kulke MD
Assistant Professor of Medicine Department of Medical Oncology
Dana-Farber Cancer Institute, Boston, MA

Transcript of lecture from the
METRO NY CARCINOID SUPPORT GROUP
Sunday, April 27, 2003
Mt Sinai Hospital, New York,…

The Role of Surgery and Chemoembolization in the Management of Carcinoid

Presented by:
Rodney Pommier, MD, FACS
Associate Professor of Surgery, Division of General Surgery,
Section of Surgical Oncology
Oregon Health Sciences University
California Carcinoid Fighters Conference
October 25, 2003

It’s a real pleasure…

Peptides and Amines: What Are They and What Do They Do?

Presented by:
Thomas M. O’Dorisio, M.D.
Professor: Department of Internal Medicine,
Division of Endocrinology and Metabolism
University of Iowa

Transcript of lecture from the
CARCINOID TREATMENT TODAY AND TOMORROW
(for Carcinoid Patients,…

New Concepts in the Treatment of Carcinoid Tumors: What’s New, What’s Not, and What’s Hot

Presented by Dr. Eugene A. Woltering, MD, FACS
The James D. Rives Professor of Surgery and Neuroscience
Chief, Sections of Surgical Endocrinology and Oncology
Director of Surgical Research
Louisiana State University Health Sciences Center

Transcript…

Cara’s Carcinoid Story

I am 43 years old, live in Illinois with my husband, and work as a college professor. I have always had good health – I run, do yoga and Pilates, and eat a fish and vegetable diet (with occasional handfuls of peanut M&M’s).

(Cara and her husband, John, on…

Multiple Endocrine Neoplasia (MEN) Patient, Family, and Medical Professionals Seminar

Multiple endocrine neoplasia (MEN) patients, their families/friends, and medical professionals are invited to attend a free, half-day education seminar presented by the Mayo Clinic in Rochester, Minnesota, in partnership with American Multiple…

Denied: Michael Farris’ Journey with Insurance for Neuroendocrine Cancer Treatment

The good news is the very positive result at the end – but the road to getting insurance coverage for Michael Farris’ participation in the PRRT (peptide receptor radionuclide therapy) clinical trial at Excel Diagnostics in Houston, Texas, was fraught…

DENIED: Michael Farris’ Journey with Insurance for Neuroendocrine Cancer Treatment

The good news is the very positive result at the end – but the road to getting insurance coverage for Michael Farris’ participation in the PRRT (peptide receptor radionuclide therapy) clinical trial at Excel Diagnostics in Houston, Texas, was fraught…

Multiple Endocrine Neoplasia (MEN) Patient and Family Seminar in Chicago

Multiple Endocrine Neoplasia 1 and 2 patients and their families are invited to a free, half-day education seminar on Saturday, March 22, 2014, presented by the Lurie Cancer Center of Northwestern University in Chicago, Illinois and American Multiple…

10 Highlights of the Year 2013 for the Carcinoid and Neuroendocrine Tumor Community

As the Carcinoid Cancer Foundation looks back on the year 2013, we reached out to physicians, patients, support group leaders, listserv managers, patient advocates, and business colleagues to see what they thought were among the highlights of the past…